Forum for Science, Industry and Business
Sponsored by:     Siemens  n-tv 
Search our Site:

Topic (optional):

 

Home Reports Life Sciences Content

Muscle weakness: New mutation identified

next article
18.06.2007

New research, published in The Journal of Physiology, has identified a novel mutation associated with muscle weakness and distal limb deformities.

 

The study demonstrates that muscle weakness experienced by persons with a regulatory protein tropomyosin mutation is directly related to a mechanism by which the mutant tropomyosin modulates contractile speed and force-generation capacity.


...more about:
muscle weakness Mutation tropomyosin weakness

Dr. Julien Ochala and co-workers at the Department of Clinical Neurophysiology, University of Uppsala, in collaboration with scientists at the Department of Pathology, University of Göteborg, explored the mechanisms underlying the muscle weakness experienced by a woman and her daughter with a β-tropomyosin mutation, i.e., muscle weakness in the absence of macro or microscopic signs of muscle wasting. The results from single fibre contractile measurements and in vitro motility analyses demonstrated a mechanism where tropomyosin modulates myosin-actin kinetics. A slower motor protein myosin attachment rate to and a faster detachment rate from actin, caused by the mutation, results in a reduced number of myosin molecules in the strong actin binding state and muscle weakness. The results also implicate a potential role of the regulatory protein tropomyosin in modulating contractile speed and force-generation under physiological conditions.

It is suggested that the findings at the gene, protein and muscle cell levels in this specific neuromuscular disorder will have a significant impact on our understanding of the disease pathogenesis and provide important information for future therapeutic strategies. Walter R. Frontera, an independent expert, says: "Dr. Ochala and collaborators have published elegant proof of the clinical consequences of mutations in the regulatory proteins of skeletal muscles. Their data provide strong support for the dissociation between qualitative alterations in muscle contractility and quantitative evidence of muscle atrophy".

Melanie Thomson | Source: EurekAlert!
Further information: www.blackwellpublishing.com

Further Reports about: muscle weakness Mutation tropomyosin weakness

next article

More articles from Life Sciences:

nachricht Scientists watch as peptides control crystal growth with ‘switches, throttles and brakes’
25.11.2009 | DOE/Lawrence Livermore National Laboratory

nachricht Arsenic and Gold Clusters
25.11.2009 | Angewandte Chemie International Edition

All articles from Life Sciences >>>

B2B Search

Product / Service
Company / Organisation

Latest News

First black holes may have incubated in giant, starlike cocoons

25.11.2009 | Physics and Astronomy

KfW issues its first ever 7 year Euro-Benchmark

25.11.2009 | Business and Finance

Intelligence inside metal components

25.11.2009 | Information Technology

VideoLinks
More VideoLinks >>>

Event News

Multidisciplinary meeting on Urological Cancers aims to benefit cancer patients

20.11.2009 | Event News

'Golden Age' for clinical psychology in Northern Ireland

20.11.2009 | Event News

New Perspectives in Marine Anti-Fouling Research

11.11.2009 | Event News